SlideShare a Scribd company logo
HYPERTENSIVE
EMERGENCIES
by
DR.A.SASIDHARAN MBBS
SLIMS, PONDICHERRY
Introduction
Most patients who presents with severe
hypertension are chronically
hypertensive and in the absence of
acute end organ damage sudden
lowering of blood pressure may result in
significant morbidity and should be
avoided.
Successful management
The main key to successful
management of severe hypertension is
to differentiate hypertensive
emergencies from hypertensive
urgencies.
definitions
Hypertensive emergency:
there is no blood pressure
threshold for diagnosis. Usually systolic
BP >180-220mm Hg and diastolic BP
>120-130mm Hg.
the main diagnosis is based on
the symptoms and signs produced due
to acute target organ damage
Cont.…
Hypertensive urgencies:
severe elevation of blood
pressure >180/120 mm Hg
without symptoms and signs of
acute target organ involvement
Treatment:
to lower BP within 24 hrs by
administration of oral antihypertensive.
Hypertensive Emergencies
Malignant hypertension:
it is a syndrome associated with
sudden increase of BP in a patient with
underlying hypertension or related to the
sudden onset of hypertension in a
previously normotensive individual
Case Scenarios
 A 56 yo CM with no significant PMH presents
to the ER with headache,found to have BP
210/110mmHg and papilledema.
 An 82 yo male with h/o HTN,chronic renal
insufficiency presents for a routine
physical,found to have BP of 230/130mmHg.
 A 76 yo female is brought to the ER by the
family due to altered mental status.BP is
240/110 mmHg with no focal neuro findings.
DEFINITIONS
 Systolic blood pressure >220 and diastolic >120mmHg.
 Patients with hypertension can be classified into 3 categories
based upon their symptoms and the organ systems that are
affected at the time of presentation:
-HYPERTENSIVE EMERGENCY: also called hypertensive crisis, is severe
hypertension with acute impairment of an organ system (e.g.,
central nervous system [CNS], cardiovascular, renal). In these
conditions, the blood pressure (BP) should be lowered aggressively
over minutes to hours.Presence of papilledema indicates
MALIGNANT HYPERTENSION.
-HYPERTENSIVE URGENCY: the BP is a potential risk but has not yet
caused acute end-organ damage. These patients require BP
control over several days to weeks.
-ACCELERATED HYPERTENSION: recent significant increase over
baseline blood pressure that is associated with target organ
damage. This is usually vascular damage on fundoscopic
examination, such as flame-shaped hemorrhages or soft exudates,
but without papilledema.
PATHOPHYSIOLOGY
NORMAL
AUTOREGULATION
RISE IN BP
ARTERIAL AND
ARTERIOLAR
CONSTRICTION
Normal flow.(flow=P/r)
RISE IN BP
FAILURE OF
VASOCONSTRICTION
ENDOTHELIAL DAMAGE
(due to shear stress on the
wall)
AUTOREGULATION
FAILURE
PATHOPHYSIOLOGY
 BP=PVR*CO(SV*HR)
 Rate at which MAP rises more important than absolute rise.
Acute rise in BP Failure of vasoconstriction Endothelial
by autoregulation damage
FIBRINOID Activates coagn and Depsn. of proteins/
NECROSIS inflammation fibrinogen in vessel
wall
 RAAS plays an important role in initiating and perpetuating BP rise by causing
vasoconstriction and fluid retention.
CENTRAL NERVOUS
SYSTEM
 CENTRAL NERVOUS SYSTEM: The CNS is affected as the
elevated BP overwhelms the normal cerebral autoregulation.
Under normal circumstances, with an increase in BP, cerebral
arterioles vasoconstrict and cerebral blood flow (CBF) remains
constant. During a hypertensive emergency, the elevated BP
overwhelms arteriolar control over vasoconstriction and
autoregulation of CBF. This results in transudate leak across
capillaries and continued arteriolar damage. Subsequent
fibrinoid necrosis causes normal autoregulatory mechanisms to
fail, leading to clinically apparent papilledema, the sine qua
non of malignant hypertension. The end result of loss of
autoregulation is hypertensive encephalopathy.
CARDIOVASCULAR
SYSTEM
 The cardiovascular system is affected as
increased cardiac workload leads to cardiac
failure; this is accompanied by pulmonary
edema, myocardial ischemia, or myocardial
infarction.
RENAL SYSTEM
 The renal system is impaired when high BP leads
to arteriosclerosis, fibrinoid necrosis, and an
overall impairment of renal protective
autoregulation mechanisms. This may manifest as
worsening renal function, hematuria, red blood
cell (RBC) cast formation, and/or proteinuria.
HISTORY
 Focus on circumstances surrounding hypertension & etiology :
-Medications:esp. hypertensive drugs/their compliance,illicit drugs
-Duration of hypertension
-Duration of current symptoms
-Date of LMP
-Other medical problems:prior
hypertension,thyrotoxicosis,Cushing’s,SLE,renal
 Focus on complications :
-CNS:headaches,blurred vision,wt.
loss,nausea,vomiting,weakness,fatigue,
confusion and mental status changes.
-CVS:symptoms of CHF,angina,dissection,SOB
-Renal:hematuria,oliguria.
PHYSICAL
 Use an approach based on organ systems to
identify signs of end-organ damage
-CNS: focal neuro deficits,seizures,stupor,coma,
papilledema, hemorrhages, exudates, or
evidence of closed-angle glaucoma
-CVS:JVD,lung auscultaion for crackles,peripheral
edema,extra heart sounds, equal and symmetric
BP and pulses bilaterally.
-Check for abdominal masses and bruits.
TREATMENT
 Weigh benefits of decreasing BP against risks of
decreasing end-organ perfusion. Important steps
include:
-Appropriately evaluating patients with an
elevated BP
-Correctly classifying the hypertension
-Determining aggressiveness of therapy
An important point to remember in the
management of the patient with any degree of
BP elevation is to "treat the patient and not the
number."
Treatment
 Initial considerations: Place patient who is not in
distress in a quiet room and reevaluate after an initial
interview. In one study, 27% of patients with an initial DBP
>130 mm Hg had their DBP fall below critical levels after
relaxation without specific treatment.
 Consider the context of the elevated BP (eg, severe pain)
 Screen for end-organ damage- Patients with end-organ
damage usually require admission and rapid lowering of
BP using iv meds.Suggested meds depend on the end-
organ system damaged.
 Patients without evidence of end-organ effects may be
discharged with follow–up.It is a misconception that a
patient should not be discharged from the ER with
elevated BP.Giving oral meds such as nifedipine to rapidly
lower BP may be dangerous as the BP may have been
elevated for sometime and there may be organ
hypoperfusion.Acute control has not improved long term
mortality and morbidity rates.
INITIAL STEPS
 Initial considerations: Place patient who is not in
distress in a quiet room and reevaluate after an initial
interview. In one study, 27% of patients with an initial DBP
>130 mm Hg had their DBP fall below critical levels after
relaxation without specific treatment.
 Consider the context of the elevated BP (eg, severe pain)
 Screen for end-organ damage- Patients with end-organ
damage usually require admission and rapid lowering of
BP using iv meds.Suggested meds depend on the end-
organ system damaged.
 Patients without evidence of end-organ effects may be
discharged with follow–up.It is a misconception that a
patient should not be discharged from the ER with
elevated BP. Giving oral meds such as nifedipine to rapidly
lower BP may be dangerous as the BP may have been
elevated for sometime and there may be organ
hypoperfusion.Acute control has not improved long term
mortality and morbidity rates.
DRUGS
 Once the diagnosis of hypertension is
made and end-organ damage
confirmed,the BP should be lowered by
about 25% of the mean arterial pressure.
 There are 2 main classes of drugs:
-Vasodilators
-Adrenergic inhibitors
VASODILATORS
DRUG DOSAGE ONSET/DUR ADV.EFFE
Nitroprusside 0.25-
10mcg/kg/min
Instant/1-2min. Thiocyanate,cyani
de poisoning
Nitroglycerine 5-100mcg/min 1-5min/3-5min Flushing,headach
e,methemoglobin
Nicardipine 5-15mg/hr 5-10min/1-4hr Tachycardia,flushin
g.avoid-heart failure
Hydralazine 10-20mg 5-15min/3-8hr Flushing,tachy,avoid
-A.diss,MI
Enalapril 10-40mg IM,1.25-
5MG1Vq6hr
20-30min/6hr Hypotension,renal
failure,hyperkalemia
Fenoldopam 0.1-
0.3mcg/kg/min
5min/10-15min Flushing,headache,t
achy
DRUG DOSAGE ONSET/DUR ADV.EFF
Labetalol
(a+b blocker)
20-80mgiv bolus
every 10
min,2mg.min iv
infusion
5-10min/3-6hrs Heart block,ortho
hypotension.avoid-
heart failure,asthma
Esmolol
(b-1 selective
blocker)
200-500
mcg/kg/min for
4min,then 150-
300mcg/kg/min
1-2min/10-20min Hypotension,avoid-
heart failure,asthma
Phentolamine
(a1 blocker)
5-15mg iv 1-2min/3-10min Tachycardia,flushin
g,headache
ADRENERGIC INHIBITORS
ORAL DRUGS
DRUG DOSAGE ONSET/D
URATION
ADV. EFF.
CAPTOPRIL
(ACE inhibitor)
6.25-25MG q
6hrs.
15-30min/6 hrs. Hypotension in
high renin states
CLONIDINE
(a2 agonist-
centrally acting)
0.1-0.2 mg hrly,
Upto max 0.8mg
in 24hrs.
30-60min/6-
12hrs.
Sedation,bradyc
ardia,dry mouth
LABETALOL 100-200mg q
12hrs
30-120min/8-
12hrs
Heart
failure,heart
block,bronchosp
asm
RAPID BP REDUCTION
 Acute myocardial ischemia:IV NTG,b-
blockers,ACE inhibitors.
 CHF with pulmonary edema:iv
NTG,furosemide,morphine
 Acute aortic dissection:iv nitroprusside+b-
blockers or iv trimethaphan+b-blockers.
 Hypertensive encephalopathy or sub-
arachnoid hemorrhage:iv
nitroprusside,labetalol or nimodipine.
 MAO-tyramine interactions with acute
hypertension:iv phentolamine.
SPECIFIC TREATMENT
 Hypertensive Encephalopathy: Goal is to reduce MAP by not>25%
or DBP tp100mmHg in the first hour.Nitroprussi(widely used in past)is a
powerful arteriloar dilator,so a rise in ICP may occur.Labetalol,fenoldopam
used more now.
 Intracerebral Hemorrhage: CPP=MAP-ICP.As ICP rises,MAP must rise
for perfusion but this raises risk of bleeding from small arteries and arterioles.A
prosp. Obs. study in 1997 did not confirm these concerns but it was obscured
by early use of anti-hypertensives.Cerebral autoregulation curve in chronic
hypertensives may be altered,making them less likely to tolerate aggressive
lowering of BP.MAP guidelines:decrease when MAP>130 or
SBP>220.Labetalol,esmolol agents of choice.
 SAH: Nimodipine decreases vasospasm that occurs due to chemical
irritation of arteries by blood.Not recommended routinely due to high
incidence of hypotension.Cognitive status is a guide.Labetalol,esmolol
agents of choice.
 Acute Ischemic Stroke: High BP can cause hemorrhagic
transformation of infarct ,cerebral edema.But,if CPP is low,ischemic
penumbra may occur.CPP beyond obstn is low.Distal vessels become dilated
with ,loss of autoregulation.A decilne to pre-stroke values in 4 days has been
documented often..A Cochrane review examining 65 RCTs with 11,500 pts.
Concluded that insufficient data exists to evaluate BP lowering post-
stroke.AHA guidelines:BP be reduced only if SBP>220 or DBP>120mmHg.
(unless end-organ damage is due to BP).Labetalol,nitroprusside-agents of
choice.For thrombolysis,BP<185/110.
Specific Treatment
 Aortic dissection: Immediate redn. In BP and
mainly,shear stress(change in BP with change in time) is
essential to limit the extension of damage as surgery is
being considered.Eliminate pain and reduce systolic
BP to 100-120 or lowest level that permits perusion.BP
redn should proceed with redn.in force of LV
contraction. Labetalol or nitroprusside+b-blocker like
propranolol agents of choice.
 MI: NTG,b-blockers,ACE inhibitors.
 Acute LVF: usually associated with pulm edema and
diastolic/systolic dysfx. IV nitroprusside,NTG agents of
choice.Titrate until BP controlled and signs of heart
failure alleviated.
 Renal insufficiency: is a cause and effect of high
BP.Goal is to prevent further renal damage by
maintaining adequate blood flow.Nitroprusside
effective.
COMPLICATIONS
 CHF
 Myocardial infarction
 Renal failure
 Retinopathy
 CVA
 Abrupt lowering of the BP may result in inadequate
cerebral or cardiac blood flow leading to stroke or
myocardial infarction.
PROGNOSIS:Median survival duration is 144 months
for all patients presenting to ED with hypertensive
emergency.
-5 yr survival rate is 74%.
FOLLOW-UP
 The Joint National Committee on High Blood
Pressure has published a series of
recommendations for appropriate follow-up,
assuming no end-organ damage.
-For a systolic BP 140-159 mm Hg/diastolic 90-99
mm Hg, confirm BP within 2 months.
-For systolic BP 160-179 mm Hg/diastolic 100-109
mm Hg, evaluate within a month.
- For systolic BP 180-209 mm Hg/diastolic 110-119
mm Hg, evaluate within a week.
-For systolic BP greater than 210 mm Hg/diastolic
greater than 120 mm Hg, evaluate immediately.
SBP-mmHg DBP-mmHg
NORMAL <120 AND<80
PREHYPERTENSION 120-139 or 80-89
STAGE 1 140-159 or 90-99
STAGE 2 >=160 >=100
HYPERTENSION(JNC-7class.)
TRIALS
 HYPERTENSIVE EMERGENCY:1 RCT
 HYPERTENSIVE URGENCY:10 RCTS.
CONCLUSIONS:-Evidence about effectiveness
of antihypertensive agents in people with
hypertensive emergencies or hypertensive
urgencies is weak. Studies had small sample
sizes and were heterogeneous in terms of
patients, interventions and outcomes
reported. Limited evidence suggests that
urapidil is most effective in emergencies. In
urgencies, nicardipine; nitroprusside or
fenolodopam may be used, but not
nifedipine.
So,……….
 A 56 yo CM with no significant PMH presents
to the ER with headache,found to have BP
210/110mmHg and papilledema.
-MALIGNANT HYPERTENSION
 An 82 yo male with h/o HTN,chronic renal
insufficiency presents for a routine
physical,found to have BP of 230/130mmHg.-
ACCELERATED HYPERTENSION
 A 76 yo female is brought to the ER by the
family due to altered mental status.BP is
240/110 mmHg with no focal neuro findings. –
HYPERTENSIVE EMERGENCY

More Related Content

What's hot

Hypertensive crisis : Detection and management in Ed
Hypertensive  crisis : Detection and management in EdHypertensive  crisis : Detection and management in Ed
Hypertensive crisis : Detection and management in Ed
Dr.Venugopalan Poovathum Parambil
 
Hypertensive emergencies management
Hypertensive emergencies managementHypertensive emergencies management
Hypertensive emergencies management
DR VISHNU RS
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisisSMSRAZA
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
Aizuddin Misro
 
Hypertensive Emergencies & ICU
Hypertensive Emergencies &  ICUHypertensive Emergencies &  ICU
Hypertensive Emergencies & ICU
Muhammad Asim Rana
 
Htn urgency and emg
Htn urgency and emgHtn urgency and emg
Htn urgency and emgSudhir Dev
 
Hypertensive Emergency
Hypertensive EmergencyHypertensive Emergency
Hypertensive Emergencydpark419
 
L3..hypertension
L3..hypertensionL3..hypertension
L3..hypertension
Muhyadin Hassan
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
NurunnobiKhondker
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
HOSPITALPONTIANJOHOR
 
HYPERTENSION
HYPERTENSIONHYPERTENSION
HYPERTENSION
leekay13
 
Hypertension
HypertensionHypertension
Hypertension
samirelansary
 
HYPERTENSIVE EMERGENCY
HYPERTENSIVE EMERGENCYHYPERTENSIVE EMERGENCY
HYPERTENSIVE EMERGENCY
ISF COLLEGE OF PHARMACY MOGA
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
Maged Abulmagd
 
Hypertensive urgency
Hypertensive urgencyHypertensive urgency
Hypertensive urgencyReynel Dan
 
Hypertensive emergency
Hypertensive emergencyHypertensive emergency
Hypertensive emergency
Dokka Srinivasu
 
Heypertensive Emergency
Heypertensive EmergencyHeypertensive Emergency
Heypertensive Emergency
Mekelle Universty
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
Ackeime Campbell
 
Hypertensive emergency and urgency
Hypertensive emergency and urgencyHypertensive emergency and urgency
Hypertensive emergency and urgency
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 

What's hot (20)

Hypertensive crisis : Detection and management in Ed
Hypertensive  crisis : Detection and management in EdHypertensive  crisis : Detection and management in Ed
Hypertensive crisis : Detection and management in Ed
 
Hypertensive emergencies management
Hypertensive emergencies managementHypertensive emergencies management
Hypertensive emergencies management
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Hypertensive Emergencies & ICU
Hypertensive Emergencies &  ICUHypertensive Emergencies &  ICU
Hypertensive Emergencies & ICU
 
Htn urgency and emg
Htn urgency and emgHtn urgency and emg
Htn urgency and emg
 
Hypertensive Emergency
Hypertensive EmergencyHypertensive Emergency
Hypertensive Emergency
 
L3..hypertension
L3..hypertensionL3..hypertension
L3..hypertension
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
HYPERTENSION
HYPERTENSIONHYPERTENSION
HYPERTENSION
 
Hypertension
HypertensionHypertension
Hypertension
 
HYPERTENSIVE EMERGENCY
HYPERTENSIVE EMERGENCYHYPERTENSIVE EMERGENCY
HYPERTENSIVE EMERGENCY
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Hypertensive urgency
Hypertensive urgencyHypertensive urgency
Hypertensive urgency
 
Hypertensive emergency
Hypertensive emergencyHypertensive emergency
Hypertensive emergency
 
Hypertension
HypertensionHypertension
Hypertension
 
Heypertensive Emergency
Heypertensive EmergencyHeypertensive Emergency
Heypertensive Emergency
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
 
Hypertensive emergency and urgency
Hypertensive emergency and urgencyHypertensive emergency and urgency
Hypertensive emergency and urgency
 

Similar to Sasi hypertensive emergensies

Hypertensi Emergency-1.ppt
Hypertensi Emergency-1.pptHypertensi Emergency-1.ppt
Hypertensi Emergency-1.ppt
RioPutraPamungkas
 
Hypertension , crf post renal transplant patient for surgery
Hypertension , crf post renal transplant patient for surgeryHypertension , crf post renal transplant patient for surgery
Hypertension , crf post renal transplant patient for surgeryDr Kumar
 
Approach-to-HTN-and-Its-managements.pptx
Approach-to-HTN-and-Its-managements.pptxApproach-to-HTN-and-Its-managements.pptx
Approach-to-HTN-and-Its-managements.pptx
tiwidoh907
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
Myiesha Taylor
 
Approach to the severe hypertension (3)
Approach to the severe hypertension (3)Approach to the severe hypertension (3)
Approach to the severe hypertension (3)
AnjaniJha10
 
Essential hypertension management and treatment
Essential hypertension management  and treatmentEssential hypertension management  and treatment
Essential hypertension management and treatment
Fabio Grubba
 
Presentation1 (8).pptx
Presentation1 (8).pptxPresentation1 (8).pptx
Presentation1 (8).pptx
jiregnaetichadako
 
hypertension with bilateral renal artery stensosis
hypertension with bilateral renal artery stensosishypertension with bilateral renal artery stensosis
hypertension with bilateral renal artery stensosis
Ramachandra Barik
 
Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertensionSachin Verma
 
Hypertension according to harrison
Hypertension according to harrison Hypertension according to harrison
Hypertension according to harrison
رازي خوري
 
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
saikrishna361975
 
Hypertension
HypertensionHypertension
Hypertension
salman habeeb
 
Understanding hypertension
Understanding hypertensionUnderstanding hypertension
Understanding hypertension
Reynel Dan
 
HTN E & U(1) (1).pptx
HTN E & U(1) (1).pptxHTN E & U(1) (1).pptx
HTN E & U(1) (1).pptx
MebratGebreyesus
 
HypertenEmerg.ppt
HypertenEmerg.pptHypertenEmerg.ppt
HypertenEmerg.ppt
Shashi Sudhakar
 
HYPERTENSION EMERGENCY & URGENCY
HYPERTENSION EMERGENCY & URGENCYHYPERTENSION EMERGENCY & URGENCY
HYPERTENSION EMERGENCY & URGENCY
Abhinav Srivastava
 
Hypertension Emergencies and their managementpptx
Hypertension Emergencies and their managementpptxHypertension Emergencies and their managementpptx
Hypertension Emergencies and their managementpptx
UzomaBende
 
hypertension.pptx
hypertension.pptxhypertension.pptx
hypertension.pptx
NgulakehBlaise1
 

Similar to Sasi hypertensive emergensies (20)

Hypertensi Emergency-1.ppt
Hypertensi Emergency-1.pptHypertensi Emergency-1.ppt
Hypertensi Emergency-1.ppt
 
Hypertension , crf post renal transplant patient for surgery
Hypertension , crf post renal transplant patient for surgeryHypertension , crf post renal transplant patient for surgery
Hypertension , crf post renal transplant patient for surgery
 
Approach-to-HTN-and-Its-managements.pptx
Approach-to-HTN-and-Its-managements.pptxApproach-to-HTN-and-Its-managements.pptx
Approach-to-HTN-and-Its-managements.pptx
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
 
Approach to the severe hypertension (3)
Approach to the severe hypertension (3)Approach to the severe hypertension (3)
Approach to the severe hypertension (3)
 
Essential hypertension management and treatment
Essential hypertension management  and treatmentEssential hypertension management  and treatment
Essential hypertension management and treatment
 
Presentation1 (8).pptx
Presentation1 (8).pptxPresentation1 (8).pptx
Presentation1 (8).pptx
 
Hypertension
HypertensionHypertension
Hypertension
 
hypertension with bilateral renal artery stensosis
hypertension with bilateral renal artery stensosishypertension with bilateral renal artery stensosis
hypertension with bilateral renal artery stensosis
 
Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertension
 
Hypertension according to harrison
Hypertension according to harrison Hypertension according to harrison
Hypertension according to harrison
 
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
 
Hypertension
HypertensionHypertension
Hypertension
 
Understanding hypertension
Understanding hypertensionUnderstanding hypertension
Understanding hypertension
 
HTN E & U(1) (1).pptx
HTN E & U(1) (1).pptxHTN E & U(1) (1).pptx
HTN E & U(1) (1).pptx
 
HypertenEmerg.ppt
HypertenEmerg.pptHypertenEmerg.ppt
HypertenEmerg.ppt
 
HYPERTENSION EMERGENCY & URGENCY
HYPERTENSION EMERGENCY & URGENCYHYPERTENSION EMERGENCY & URGENCY
HYPERTENSION EMERGENCY & URGENCY
 
Hypertension Emergencies and their managementpptx
Hypertension Emergencies and their managementpptxHypertension Emergencies and their managementpptx
Hypertension Emergencies and their managementpptx
 
hypertension.pptx
hypertension.pptxhypertension.pptx
hypertension.pptx
 

More from doctor / pediatrician

22.07.2019 ACUTE SEVERE ASTHMA copy.pptx
22.07.2019 ACUTE SEVERE ASTHMA copy.pptx22.07.2019 ACUTE SEVERE ASTHMA copy.pptx
22.07.2019 ACUTE SEVERE ASTHMA copy.pptx
doctor / pediatrician
 
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdfIndications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
doctor / pediatrician
 
bloodvesselsoflowerlimb-230302034633-5d194285.pdf
bloodvesselsoflowerlimb-230302034633-5d194285.pdfbloodvesselsoflowerlimb-230302034633-5d194285.pdf
bloodvesselsoflowerlimb-230302034633-5d194285.pdf
doctor / pediatrician
 
PID presentation.pptx
PID presentation.pptxPID presentation.pptx
PID presentation.pptx
doctor / pediatrician
 
Basics of ECG.pptx
Basics of ECG.pptxBasics of ECG.pptx
Basics of ECG.pptx
doctor / pediatrician
 
CENTRAL VENOUS ACCESS / PROCEDURES IN PICU
CENTRAL VENOUS ACCESS / PROCEDURES IN PICU CENTRAL VENOUS ACCESS / PROCEDURES IN PICU
CENTRAL VENOUS ACCESS / PROCEDURES IN PICU
doctor / pediatrician
 
Journal club in PICU
Journal club in PICU Journal club in PICU
Journal club in PICU
doctor / pediatrician
 
Hydrocarbon poisoning
Hydrocarbon poisoningHydrocarbon poisoning
Hydrocarbon poisoning
doctor / pediatrician
 
ECG BASICS
ECG BASICS ECG BASICS
Sasi ARTERIAL BLOOD GAS ANALYSIS
Sasi ARTERIAL BLOOD GAS ANALYSIS Sasi ARTERIAL BLOOD GAS ANALYSIS
Sasi ARTERIAL BLOOD GAS ANALYSIS
doctor / pediatrician
 
IV Ig Resistant Kawasaki Disease
IV Ig Resistant Kawasaki Disease IV Ig Resistant Kawasaki Disease
IV Ig Resistant Kawasaki Disease
doctor / pediatrician
 
SURGERY SHORT CASES
SURGERY SHORT CASES SURGERY SHORT CASES
SURGERY SHORT CASES
doctor / pediatrician
 

More from doctor / pediatrician (12)

22.07.2019 ACUTE SEVERE ASTHMA copy.pptx
22.07.2019 ACUTE SEVERE ASTHMA copy.pptx22.07.2019 ACUTE SEVERE ASTHMA copy.pptx
22.07.2019 ACUTE SEVERE ASTHMA copy.pptx
 
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdfIndications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
 
bloodvesselsoflowerlimb-230302034633-5d194285.pdf
bloodvesselsoflowerlimb-230302034633-5d194285.pdfbloodvesselsoflowerlimb-230302034633-5d194285.pdf
bloodvesselsoflowerlimb-230302034633-5d194285.pdf
 
PID presentation.pptx
PID presentation.pptxPID presentation.pptx
PID presentation.pptx
 
Basics of ECG.pptx
Basics of ECG.pptxBasics of ECG.pptx
Basics of ECG.pptx
 
CENTRAL VENOUS ACCESS / PROCEDURES IN PICU
CENTRAL VENOUS ACCESS / PROCEDURES IN PICU CENTRAL VENOUS ACCESS / PROCEDURES IN PICU
CENTRAL VENOUS ACCESS / PROCEDURES IN PICU
 
Journal club in PICU
Journal club in PICU Journal club in PICU
Journal club in PICU
 
Hydrocarbon poisoning
Hydrocarbon poisoningHydrocarbon poisoning
Hydrocarbon poisoning
 
ECG BASICS
ECG BASICS ECG BASICS
ECG BASICS
 
Sasi ARTERIAL BLOOD GAS ANALYSIS
Sasi ARTERIAL BLOOD GAS ANALYSIS Sasi ARTERIAL BLOOD GAS ANALYSIS
Sasi ARTERIAL BLOOD GAS ANALYSIS
 
IV Ig Resistant Kawasaki Disease
IV Ig Resistant Kawasaki Disease IV Ig Resistant Kawasaki Disease
IV Ig Resistant Kawasaki Disease
 
SURGERY SHORT CASES
SURGERY SHORT CASES SURGERY SHORT CASES
SURGERY SHORT CASES
 

Recently uploaded

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 

Recently uploaded (20)

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 

Sasi hypertensive emergensies

  • 2. Introduction Most patients who presents with severe hypertension are chronically hypertensive and in the absence of acute end organ damage sudden lowering of blood pressure may result in significant morbidity and should be avoided.
  • 3. Successful management The main key to successful management of severe hypertension is to differentiate hypertensive emergencies from hypertensive urgencies.
  • 4. definitions Hypertensive emergency: there is no blood pressure threshold for diagnosis. Usually systolic BP >180-220mm Hg and diastolic BP >120-130mm Hg. the main diagnosis is based on the symptoms and signs produced due to acute target organ damage
  • 5. Cont.… Hypertensive urgencies: severe elevation of blood pressure >180/120 mm Hg without symptoms and signs of acute target organ involvement Treatment: to lower BP within 24 hrs by administration of oral antihypertensive.
  • 6. Hypertensive Emergencies Malignant hypertension: it is a syndrome associated with sudden increase of BP in a patient with underlying hypertension or related to the sudden onset of hypertension in a previously normotensive individual
  • 7. Case Scenarios  A 56 yo CM with no significant PMH presents to the ER with headache,found to have BP 210/110mmHg and papilledema.  An 82 yo male with h/o HTN,chronic renal insufficiency presents for a routine physical,found to have BP of 230/130mmHg.  A 76 yo female is brought to the ER by the family due to altered mental status.BP is 240/110 mmHg with no focal neuro findings.
  • 8. DEFINITIONS  Systolic blood pressure >220 and diastolic >120mmHg.  Patients with hypertension can be classified into 3 categories based upon their symptoms and the organ systems that are affected at the time of presentation: -HYPERTENSIVE EMERGENCY: also called hypertensive crisis, is severe hypertension with acute impairment of an organ system (e.g., central nervous system [CNS], cardiovascular, renal). In these conditions, the blood pressure (BP) should be lowered aggressively over minutes to hours.Presence of papilledema indicates MALIGNANT HYPERTENSION. -HYPERTENSIVE URGENCY: the BP is a potential risk but has not yet caused acute end-organ damage. These patients require BP control over several days to weeks. -ACCELERATED HYPERTENSION: recent significant increase over baseline blood pressure that is associated with target organ damage. This is usually vascular damage on fundoscopic examination, such as flame-shaped hemorrhages or soft exudates, but without papilledema.
  • 9. PATHOPHYSIOLOGY NORMAL AUTOREGULATION RISE IN BP ARTERIAL AND ARTERIOLAR CONSTRICTION Normal flow.(flow=P/r) RISE IN BP FAILURE OF VASOCONSTRICTION ENDOTHELIAL DAMAGE (due to shear stress on the wall) AUTOREGULATION FAILURE
  • 10. PATHOPHYSIOLOGY  BP=PVR*CO(SV*HR)  Rate at which MAP rises more important than absolute rise. Acute rise in BP Failure of vasoconstriction Endothelial by autoregulation damage FIBRINOID Activates coagn and Depsn. of proteins/ NECROSIS inflammation fibrinogen in vessel wall  RAAS plays an important role in initiating and perpetuating BP rise by causing vasoconstriction and fluid retention.
  • 11. CENTRAL NERVOUS SYSTEM  CENTRAL NERVOUS SYSTEM: The CNS is affected as the elevated BP overwhelms the normal cerebral autoregulation. Under normal circumstances, with an increase in BP, cerebral arterioles vasoconstrict and cerebral blood flow (CBF) remains constant. During a hypertensive emergency, the elevated BP overwhelms arteriolar control over vasoconstriction and autoregulation of CBF. This results in transudate leak across capillaries and continued arteriolar damage. Subsequent fibrinoid necrosis causes normal autoregulatory mechanisms to fail, leading to clinically apparent papilledema, the sine qua non of malignant hypertension. The end result of loss of autoregulation is hypertensive encephalopathy.
  • 12. CARDIOVASCULAR SYSTEM  The cardiovascular system is affected as increased cardiac workload leads to cardiac failure; this is accompanied by pulmonary edema, myocardial ischemia, or myocardial infarction.
  • 13. RENAL SYSTEM  The renal system is impaired when high BP leads to arteriosclerosis, fibrinoid necrosis, and an overall impairment of renal protective autoregulation mechanisms. This may manifest as worsening renal function, hematuria, red blood cell (RBC) cast formation, and/or proteinuria.
  • 14. HISTORY  Focus on circumstances surrounding hypertension & etiology : -Medications:esp. hypertensive drugs/their compliance,illicit drugs -Duration of hypertension -Duration of current symptoms -Date of LMP -Other medical problems:prior hypertension,thyrotoxicosis,Cushing’s,SLE,renal  Focus on complications : -CNS:headaches,blurred vision,wt. loss,nausea,vomiting,weakness,fatigue, confusion and mental status changes. -CVS:symptoms of CHF,angina,dissection,SOB -Renal:hematuria,oliguria.
  • 15. PHYSICAL  Use an approach based on organ systems to identify signs of end-organ damage -CNS: focal neuro deficits,seizures,stupor,coma, papilledema, hemorrhages, exudates, or evidence of closed-angle glaucoma -CVS:JVD,lung auscultaion for crackles,peripheral edema,extra heart sounds, equal and symmetric BP and pulses bilaterally. -Check for abdominal masses and bruits.
  • 16. TREATMENT  Weigh benefits of decreasing BP against risks of decreasing end-organ perfusion. Important steps include: -Appropriately evaluating patients with an elevated BP -Correctly classifying the hypertension -Determining aggressiveness of therapy An important point to remember in the management of the patient with any degree of BP elevation is to "treat the patient and not the number."
  • 17. Treatment  Initial considerations: Place patient who is not in distress in a quiet room and reevaluate after an initial interview. In one study, 27% of patients with an initial DBP >130 mm Hg had their DBP fall below critical levels after relaxation without specific treatment.  Consider the context of the elevated BP (eg, severe pain)  Screen for end-organ damage- Patients with end-organ damage usually require admission and rapid lowering of BP using iv meds.Suggested meds depend on the end- organ system damaged.  Patients without evidence of end-organ effects may be discharged with follow–up.It is a misconception that a patient should not be discharged from the ER with elevated BP.Giving oral meds such as nifedipine to rapidly lower BP may be dangerous as the BP may have been elevated for sometime and there may be organ hypoperfusion.Acute control has not improved long term mortality and morbidity rates.
  • 18. INITIAL STEPS  Initial considerations: Place patient who is not in distress in a quiet room and reevaluate after an initial interview. In one study, 27% of patients with an initial DBP >130 mm Hg had their DBP fall below critical levels after relaxation without specific treatment.  Consider the context of the elevated BP (eg, severe pain)  Screen for end-organ damage- Patients with end-organ damage usually require admission and rapid lowering of BP using iv meds.Suggested meds depend on the end- organ system damaged.  Patients without evidence of end-organ effects may be discharged with follow–up.It is a misconception that a patient should not be discharged from the ER with elevated BP. Giving oral meds such as nifedipine to rapidly lower BP may be dangerous as the BP may have been elevated for sometime and there may be organ hypoperfusion.Acute control has not improved long term mortality and morbidity rates.
  • 19. DRUGS  Once the diagnosis of hypertension is made and end-organ damage confirmed,the BP should be lowered by about 25% of the mean arterial pressure.  There are 2 main classes of drugs: -Vasodilators -Adrenergic inhibitors
  • 20. VASODILATORS DRUG DOSAGE ONSET/DUR ADV.EFFE Nitroprusside 0.25- 10mcg/kg/min Instant/1-2min. Thiocyanate,cyani de poisoning Nitroglycerine 5-100mcg/min 1-5min/3-5min Flushing,headach e,methemoglobin Nicardipine 5-15mg/hr 5-10min/1-4hr Tachycardia,flushin g.avoid-heart failure Hydralazine 10-20mg 5-15min/3-8hr Flushing,tachy,avoid -A.diss,MI Enalapril 10-40mg IM,1.25- 5MG1Vq6hr 20-30min/6hr Hypotension,renal failure,hyperkalemia Fenoldopam 0.1- 0.3mcg/kg/min 5min/10-15min Flushing,headache,t achy
  • 21. DRUG DOSAGE ONSET/DUR ADV.EFF Labetalol (a+b blocker) 20-80mgiv bolus every 10 min,2mg.min iv infusion 5-10min/3-6hrs Heart block,ortho hypotension.avoid- heart failure,asthma Esmolol (b-1 selective blocker) 200-500 mcg/kg/min for 4min,then 150- 300mcg/kg/min 1-2min/10-20min Hypotension,avoid- heart failure,asthma Phentolamine (a1 blocker) 5-15mg iv 1-2min/3-10min Tachycardia,flushin g,headache ADRENERGIC INHIBITORS
  • 22. ORAL DRUGS DRUG DOSAGE ONSET/D URATION ADV. EFF. CAPTOPRIL (ACE inhibitor) 6.25-25MG q 6hrs. 15-30min/6 hrs. Hypotension in high renin states CLONIDINE (a2 agonist- centrally acting) 0.1-0.2 mg hrly, Upto max 0.8mg in 24hrs. 30-60min/6- 12hrs. Sedation,bradyc ardia,dry mouth LABETALOL 100-200mg q 12hrs 30-120min/8- 12hrs Heart failure,heart block,bronchosp asm
  • 23. RAPID BP REDUCTION  Acute myocardial ischemia:IV NTG,b- blockers,ACE inhibitors.  CHF with pulmonary edema:iv NTG,furosemide,morphine  Acute aortic dissection:iv nitroprusside+b- blockers or iv trimethaphan+b-blockers.  Hypertensive encephalopathy or sub- arachnoid hemorrhage:iv nitroprusside,labetalol or nimodipine.  MAO-tyramine interactions with acute hypertension:iv phentolamine.
  • 24. SPECIFIC TREATMENT  Hypertensive Encephalopathy: Goal is to reduce MAP by not>25% or DBP tp100mmHg in the first hour.Nitroprussi(widely used in past)is a powerful arteriloar dilator,so a rise in ICP may occur.Labetalol,fenoldopam used more now.  Intracerebral Hemorrhage: CPP=MAP-ICP.As ICP rises,MAP must rise for perfusion but this raises risk of bleeding from small arteries and arterioles.A prosp. Obs. study in 1997 did not confirm these concerns but it was obscured by early use of anti-hypertensives.Cerebral autoregulation curve in chronic hypertensives may be altered,making them less likely to tolerate aggressive lowering of BP.MAP guidelines:decrease when MAP>130 or SBP>220.Labetalol,esmolol agents of choice.  SAH: Nimodipine decreases vasospasm that occurs due to chemical irritation of arteries by blood.Not recommended routinely due to high incidence of hypotension.Cognitive status is a guide.Labetalol,esmolol agents of choice.  Acute Ischemic Stroke: High BP can cause hemorrhagic transformation of infarct ,cerebral edema.But,if CPP is low,ischemic penumbra may occur.CPP beyond obstn is low.Distal vessels become dilated with ,loss of autoregulation.A decilne to pre-stroke values in 4 days has been documented often..A Cochrane review examining 65 RCTs with 11,500 pts. Concluded that insufficient data exists to evaluate BP lowering post- stroke.AHA guidelines:BP be reduced only if SBP>220 or DBP>120mmHg. (unless end-organ damage is due to BP).Labetalol,nitroprusside-agents of choice.For thrombolysis,BP<185/110.
  • 25. Specific Treatment  Aortic dissection: Immediate redn. In BP and mainly,shear stress(change in BP with change in time) is essential to limit the extension of damage as surgery is being considered.Eliminate pain and reduce systolic BP to 100-120 or lowest level that permits perusion.BP redn should proceed with redn.in force of LV contraction. Labetalol or nitroprusside+b-blocker like propranolol agents of choice.  MI: NTG,b-blockers,ACE inhibitors.  Acute LVF: usually associated with pulm edema and diastolic/systolic dysfx. IV nitroprusside,NTG agents of choice.Titrate until BP controlled and signs of heart failure alleviated.  Renal insufficiency: is a cause and effect of high BP.Goal is to prevent further renal damage by maintaining adequate blood flow.Nitroprusside effective.
  • 26. COMPLICATIONS  CHF  Myocardial infarction  Renal failure  Retinopathy  CVA  Abrupt lowering of the BP may result in inadequate cerebral or cardiac blood flow leading to stroke or myocardial infarction. PROGNOSIS:Median survival duration is 144 months for all patients presenting to ED with hypertensive emergency. -5 yr survival rate is 74%.
  • 27. FOLLOW-UP  The Joint National Committee on High Blood Pressure has published a series of recommendations for appropriate follow-up, assuming no end-organ damage. -For a systolic BP 140-159 mm Hg/diastolic 90-99 mm Hg, confirm BP within 2 months. -For systolic BP 160-179 mm Hg/diastolic 100-109 mm Hg, evaluate within a month. - For systolic BP 180-209 mm Hg/diastolic 110-119 mm Hg, evaluate within a week. -For systolic BP greater than 210 mm Hg/diastolic greater than 120 mm Hg, evaluate immediately.
  • 28.
  • 29. SBP-mmHg DBP-mmHg NORMAL <120 AND<80 PREHYPERTENSION 120-139 or 80-89 STAGE 1 140-159 or 90-99 STAGE 2 >=160 >=100 HYPERTENSION(JNC-7class.)
  • 30. TRIALS  HYPERTENSIVE EMERGENCY:1 RCT  HYPERTENSIVE URGENCY:10 RCTS. CONCLUSIONS:-Evidence about effectiveness of antihypertensive agents in people with hypertensive emergencies or hypertensive urgencies is weak. Studies had small sample sizes and were heterogeneous in terms of patients, interventions and outcomes reported. Limited evidence suggests that urapidil is most effective in emergencies. In urgencies, nicardipine; nitroprusside or fenolodopam may be used, but not nifedipine.
  • 31. So,……….  A 56 yo CM with no significant PMH presents to the ER with headache,found to have BP 210/110mmHg and papilledema. -MALIGNANT HYPERTENSION  An 82 yo male with h/o HTN,chronic renal insufficiency presents for a routine physical,found to have BP of 230/130mmHg.- ACCELERATED HYPERTENSION  A 76 yo female is brought to the ER by the family due to altered mental status.BP is 240/110 mmHg with no focal neuro findings. – HYPERTENSIVE EMERGENCY